Tag: Medicine
-
Genomic ‘Memory’ Governs the Building Blocks of Life, Study Reveals
Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating the building blocks of life, according to a new study published in Science Advances.
-
Combination Therapy Improves Outcomes for Rare Blood Disorder
A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the journal Blood.
-
Mitochondria May Be a Promising Therapeutic Target for Inflammatory Diseases
Northwestern scientists have discovered how mitochondria influence the body’s immune response through modulating specific cell signaling pathways, according to a recent study published in Science Advances.
-
Investigating New Treatments for Rare Skin Lymphomas
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.
-
Redefining Obesity With New Global Guidelines
An international team of scientists has developed a new set of global clinical guidelines for obesity aimed at better diagnosing and categorizing the condition, according to a report published in The Lancet Diabetes and Endocrinology.
-
Socioeconomic Factors Drive Racial Disparities in Maternal Heart Health
A new Northwestern Medicine study has discovered that achieving equity in various social drivers of health — but particularly education — has the potential to nearly eliminate disparities in maternal heart health.
-
Potential Therapeutic Target for Ischemic Acute Kidney Injury Discovered
Investigators led by Pinelopi Kapitsinou, MD, have discovered that inhibiting the hypoxia-driven MCT4 protein in kidney endothelial cells may halt the progression of ischemic acute kidney injury to chronic kidney disease, according to a recent study published in the Journal of Clinical Investigation.
-
Improving the Treatment of Valvular Heart Diseases
Transcatheter heart valve replacement significantly improved outcomes in patients with severe valvular heart diseases compared to standard care alone, according to two recent clinical trials published in the New England Journal of Medicine.
-
Combination Therapy Does Not Extend Survival in Glioblastoma
Patients with a subtype of glioblastoma who received a combination treatment of a PARP inhibitor and standard chemotherapy did not demonstrate improved survival compared to chemotherapy and placebo, according to a recent clinical trial published in JAMA Oncology.
-
Immunotherapy Shows Potential to Treat Deadly Thyroid Cancer
A type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results of a clinical trial published in JAMA Oncology.
